Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef90fbbf846565eb48787ed4cbe073fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_570d0a65de2c811b3c2a715684a53a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ebfd716a6d868cec0fdcf2af2480107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1577d96af73d2df117503140c4de320c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_364f48766c53b58c374aeaf52065faa1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2010-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c7eb5bdc9ec4f6369b32a8b22a7c6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e49a7e8c8ae3856af4fe4535aea9424 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6ca6d82f3ad591d3a69393053c1891f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_028fafbba39ff94be67c9159709a50ad |
publicationDate |
2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8568719-B2 |
titleOfInvention |
Antibodies against human respiratory syncytial virus (RSV) and methods of use |
abstract |
Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472869-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9988437-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758591-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10400034-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301379-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9139642-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013177573-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654193-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403900-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017004499-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9739773-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688181-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10344096-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562963-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11312787-B2 |
priorityDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |